Eli Lilly and more announced recent GLP-1 clinical and preclinical data at the American Diabetes Association’s national conference this week. Eli Lilly, Novo Nordisk, AstraZeneca and more announced recent GLP-1 clinical and preclinical data at the American Diabetes Association’s (ADA’s) national conference this week. The conference was eventful, with several experts being escorted out by police after handing out copies of an editorial criticizing the Trump administration’s science policies. The editorial was published in the ADA’s flagship journal, Diabetes Care , and detailed the effects of funding cuts and other actions on diabetes research. Shortly before Jay Bhattacharya, director of…
Eli Lilly, Novo Nordisk, AstraZeneca and more announced recent GLP-1 clinical and preclinical data at the American Diabetes Association’s (ADA’s) national conference this week. The conference was eventful, with several experts being escorted out by police after handing out copies of an editorial criticizing the Trump administration’s science policies. The editorial was published in the…
The post ADA conference roundup: GLP-1 trial results and researchers removed by police appeared first on Drug Discovery and Development.
US Pharma Marketing